Real-world Clinical Effectiveness and Patient Insight Associated With Adding Sodium Glucose Co-transporter 2 Inhibitor to Gliclazide Modified Release

NCT06708091 · clinicaltrials.gov ↗
COMPLETED
Status
537
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Servier Affaires Médicales